| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5588038 | Journal of Diabetes and its Complications | 2017 | 6 Pages |
Abstract
GB surgery for overweight but not obese people with T2D appears to be cost-effective in the U.S. setting if weight loss endures for more than five years. Health utility gained from weight loss is a critical input to cost-effectiveness estimates and therefore should be routinely measured in populations undergoing bariatric surgery.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
John M. Wentworth, Kim M. Dalziel, Paul E. O'Brien, Paul Burton, Frackson Shaba, Philip M. Clarke, Neda Laiteerapong, Wendy A. Brown,